.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
Julphar
Cipla
Cerilliant
Medtronic
Novartis
Express Scripts
Chubb
Harvard Business School

Generated: December 14, 2017

DrugPatentWatch Database Preview

AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Aminosyn Ii 3.5% M In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Aminosyn Ii 3.5% M In Dextrose 5% In Plastic Container is a drug marketed by Abbott and Hospira Inc and is included in three NDAs.

The generic ingredient in AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER is amino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate. There are three hundred and forty-one drug master file entries for this compound. Additional details are available on the amino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate profile page.

Summary for AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER

Drug patent expirations by year for AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
AbbottAMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINERamino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrateINJECTABLE;INJECTION019564-001Dec 16, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AbbottAMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINERamino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrateINJECTABLE;INJECTION019712-001Sep 8, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hospira IncAMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINERamino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrateINJECTABLE;INJECTION019682-001Nov 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
UBS
Queensland Health
Dow
McKesson
Chubb
Novartis
Chinese Patent Office
Express Scripts
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot